Key result
The LARIAT procedure is a novel, minimally invasive endo-epicardial technique for left atrial appendage exclusion that mitigates stroke risk in atrial fibrillation patients with contraindications to anticoagulation.
Answers are grounded in this paper and cite their sources.
The LARIAT procedure is a minimally invasive, percutaneous endo-epicardial technique that offers a promising alternative for LAA exclusion to reduce stroke risk in AF patients contraindicated for oral anticoagulation.
Percutaneous left atrial appendage ligation (LAA) techniques have come to the forefront of management of atrial fibrillation (AF) patients who are at high risk of stroke and are unsuitable for oral anticoagulation therapy. LARIAT is a novel percutaneous endo-epicardial ligation technique for LAA exclusion. This technique is increasingly becoming popular for LAA exclusion in AF patients. A few studies have validated the efficacy of LARIAT in mitigating stroke risk in AF patients with contraindications to anticoagulation. Additionally a few studies have suggested that AF burden decreases after the LARIAT procedure. In this review paper we discuss the indications, technique and the latest advances in the LAA exclusion using the LARIAT system.
No takes yet. Share an insight, caveat, or question.
Janga et al. (2014) conducted a review in Atrial Fibrillation. LARIAT procedure was evaluated. The LARIAT procedure is a novel, minimally invasive endo-epicardial technique for left atrial appendage exclusion that mitigates stroke risk in atrial fibrillation patients with contraindications to anticoagulation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: